{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T09:18:17Z","timestamp":1778404697311,"version":"3.51.4"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T00:00:00Z","timestamp":1643068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016220","name":"Georgia Clinical and Translational Science Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016220","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016220","name":"Georgia Clinical and Translational Science Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016220","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Integrating brain imaging with large scale omics data may identify novel mechanisms of mild cognitive impairment (MCI) and early Alzheimer\u2019s disease (AD). We integrated and analyzed brain magnetic resonance imaging (MRI) with cerebrospinal fluid (CSF) metabolomics to elucidate metabolic mechanisms and create a \u201cmetabolic map\u201d of the brain in prodromal AD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In 145 subjects (85 cognitively normal controls and 60 with MCI), we derived voxel-wise gray matter volume via whole-brain structural MRI and conducted high-resolution untargeted metabolomics on CSF. Using a data-driven approach consisting of partial least squares discriminant analysis, a multiomics network clustering algorithm, and metabolic pathway analysis, we described dysregulated metabolic pathways in CSF mapped to brain regions associated with MCI in our cohort.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The multiomics network algorithm clustered metabolites with contiguous imaging voxels into seven distinct communities corresponding to the following brain regions: hippocampus\/parahippocampal gyrus (three distinct clusters), thalamus, posterior thalamus, parietal cortex, and occipital lobe. Metabolic pathway analysis indicated dysregulated metabolic activity in the urea cycle, and many amino acids (arginine, histidine, lysine, glycine, tryptophan, methionine, valine, glutamate, beta-alanine, and purine) was significantly associated with those regions (<jats:italic>P<\/jats:italic> &amp;lt; 0.05).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>By integrating CSF metabolomics data with structural MRI data, we linked specific AD-susceptible brain regions to disrupted metabolic pathways involving nitrogen excretion and amino acid metabolism critical for cognitive function. Our findings and analytical approach may extend drug and biomarker research toward more multiomics approaches.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnagi.2021.796067","type":"journal-article","created":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T09:36:14Z","timestamp":1643103374000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Multiomics Analysis of Structural Magnetic Resonance Imaging of the Brain and Cerebrospinal Fluid Metabolomics in Cognitively Normal and Impaired Adults"],"prefix":"10.3389","volume":"13","author":[{"given":"Ronald C.","family":"Eldridge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karan","family":"Uppal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahsa","family":"Shokouhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Ryan","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaohui S.","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dean P.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ihab","family":"Hajjar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"S80","DOI":"10.1097\/JOM.0000000000000770","article-title":"High-Resolution Metabolomics for Nutrition and Health Assessment of Armed Forces Personnel.","volume":"58","author":"Accardi","year":"2016","journal-title":"J. Occup. Environ. Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.mri.2011.11.001","article-title":"Partial least squares for discrimination in fMRI data.","volume":"30","author":"Andersen","year":"2012","journal-title":"Magnet. Resonance Imaging"},{"key":"B3","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.bspc.2019.04.032","article-title":"Integrating imaging and omics data: A review.","volume":"52","author":"Antonelli","year":"2019","journal-title":"Biomed. Signal Process. Control."},{"key":"B4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.neuroimage.2007.07.007","article-title":"A fast diffeomorphic image registration algorithm.","volume":"38","author":"Ashburner","year":"2007","journal-title":"Neuroimage"},{"key":"B5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/978-3-319-57379-3_16","article-title":"Integrating Omic Technologies in Alzheimer\u2019s Disease.","volume":"987","author":"Avramouli","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"10008","DOI":"10.1103\/PhysRevE.83.036103","article-title":"Fast unfolding of communities in large networks.","volume":"2008","author":"Blondel","year":"2008","journal-title":"J. Statist. Mech. Theory Exp."},{"key":"B7","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1212\/01.wnl.0000228243.56665.c2","article-title":"The contribution of voxel-based morphometry in staging patients with mild cognitive impairment.","volume":"67","author":"Bozzali","year":"2006","journal-title":"Neurology"},{"key":"B8","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/cem.2609","article-title":"Partial least squares discriminant analysis: taking the magic away.","volume":"28","author":"Brereton","year":"2014","journal-title":"J. Chemometr."},{"key":"B9","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1089\/ars.2016.6768","article-title":"Metabolic Syndrome as a Risk Factor for Alzheimer\u2019s Disease: Is A\u03b2 a Crucial Factor in Both Pathologies?","volume":"26","author":"Campos-Pe\u00f1a","year":"2017","journal-title":"Antioxid. Redox. Signal."},{"key":"B10","doi-asserted-by":"publisher","first-page":"R906","DOI":"10.1152\/ajpregu.00298.2016","article-title":"Metabolic pathways of lung inflammation revealed by high-resolution metabolomics (HRM) of H1N1 influenza virus infection in mice.","volume":"311","author":"Chandler","year":"2016","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.pneurobio.2013.06.004","article-title":"Decoding Alzheimer\u2019s disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.","volume":"108","author":"Chen","year":"2013","journal-title":"Prog. Neurobiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.jalz.2017.04.009","article-title":"Association of amine biomarkers with incident dementia and Alzheimer\u2019s disease in the Framingham Study.","volume":"13","author":"Chouraki","year":"2017","journal-title":"Alzheimer\u2019s Dement."},{"key":"B13","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.neuroimage.2010.06.013","article-title":"Automatic classification of patients with Alzheimer\u2019s disease from structural MRI: a comparison of ten methods using the ADNI database.","volume":"56","author":"Cuingnet","year":"2011","journal-title":"Neuroimage"},{"key":"B14","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.bcp.2013.12.012","article-title":"Brain metabolic dysfunction at the core of Alzheimer\u2019s disease.","volume":"88","author":"de la Monte","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.spen.2008.05.007","article-title":"Neurologic damage and neurocognitive dysfunction in urea cycle disorders.","volume":"15","author":"Enns","year":"2008","journal-title":"Semin. Pediatr. Neurol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jpba.2014.10.010","article-title":"Metabolite profiling for the identification of altered metabolic pathways in Alzheimer\u2019s disease.","volume":"107","author":"Gonz\u00e1lez-Dom\u00ednguez","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"B17","doi-asserted-by":"publisher","first-page":"5472792","DOI":"10.1155\/2017\/5472792","article-title":"Amino Acid Catabolism in Alzheimer\u2019s Disease Brain: Friend or Foe?","volume":"2017","author":"Griffin","year":"2017","journal-title":"Oxid. Med. Cell Longev."},{"key":"B18","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.aca.2015.02.012","article-title":"A tutorial review: Metabolomics and partial least squares-discriminant analysis \u2013 a marriage of convenience or a shotgun wedding.","volume":"879","author":"Gromski","year":"2015","journal-title":"Anal. Chim. Acta"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e12064","DOI":"10.1002\/dad2.12064","article-title":"Untargeted metabolomics reveal dysregulations in sugar, methionine, and tyrosine pathways in the prodromal state of AD.","volume":"12","author":"Hajjar","year":"2020","journal-title":"Alzheimer\u2019s Dement. Diagnosis Assess. Dis. Monitor."},{"key":"B20","doi-asserted-by":"crossref","first-page":"a006213","DOI":"10.1101\/cshperspect.a006213","article-title":"Brain imaging in Alzheimer disease.","volume":"2","author":"Johnson","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1093\/biostatistics\/kxj037","article-title":"Adjusting batch effects in microarray expression data using empirical Bayes methods.","volume":"8","author":"Johnson","year":"2007","journal-title":"Biostatistics"},{"key":"B22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.neucom.2014.09.072","article-title":"Early diagnosis of Alzheimer\u00d7s disease based on partial least squares, principal component analysis and support vector machine using segmented MRI images.","volume":"151","author":"Khedher","year":"2015","journal-title":"Neurocomputing"},{"key":"B23","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1093\/brain\/awm319","article-title":"Automatic classification of MR scans in Alzheimer\u2019s disease.","volume":"131","author":"Kl\u00f6ppel","year":"2008","journal-title":"Brain J. Neurol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1089\/omi.2016.0106","article-title":"Metabolic Biomarkers and Neurodegeneration: A Pathway Enrichment Analysis of Alzheimer\u2019s Disease, Parkinson\u2019s Disease, and Amyotrophic Lateral Sclerosis.","volume":"20","author":"Kori","year":"2016","journal-title":"OMICS"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e1003123","DOI":"10.1371\/journal.pcbi.1003123","article-title":"Predicting Network Activity from High Throughput Metabolomics.","volume":"9","author":"Li","year":"2013","journal-title":"PLoS Comput. Biol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"8836","DOI":"10.1021\/acs.analchem.0c00338","article-title":"Reference Standardization for Quantification and Harmonization of Large-Scale Metabolomics.","volume":"92","author":"Liu","year":"2020","journal-title":"Anal. Chem."},{"key":"B27","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.tibs.2017.01.004","article-title":"Metabolomics: A Primer.","volume":"42","author":"Liu","year":"2017","journal-title":"Trends Biochem. Sci."},{"key":"B28","first-page":"29","article-title":"Voxel-based Morphometry of Brain MRI in Normal Aging and Alzheimer\u2019s Disease.","volume":"4","author":"Matsuda","year":"2013","journal-title":"Aging Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.arr.2016.01.003","article-title":"MRI morphometry in Alzheimer\u2019s disease.","volume":"30","author":"Matsuda","year":"2016","journal-title":"Ageing Res. Rev."},{"key":"B30","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s00439-003-0921-9","article-title":"Prediction of clinical outcome with microarray data: a partial least squares discriminant analysis (PLS-DA) approach.","volume":"112","author":"P\u00e9rez-Enciso","year":"2003","journal-title":"Hum. Genet."},{"key":"B31","doi-asserted-by":"publisher","first-page":"C1","DOI":"10.1152\/ajpcell.00109.2017","article-title":"Multi-omics and Alzheimer\u2019s disease: a slower but surer path to an efficacious therapy?","volume":"313","author":"Pimplikar","year":"2017","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1111\/jon.12163","article-title":"Predictive Models Based on Support Vector Machines: Whole-Brain versus Regional Analysis of Structural MRI in the Alzheimer\u2019s Disease.","volume":"25","author":"Retico","year":"2015","journal-title":"J. Neuroimaging"},{"key":"B33","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1111\/j.1532-5415.2008.01684.x","article-title":"Magnetic resonance imaging characterization of brain structure and function in mild cognitive impairment: a review.","volume":"56","author":"Ries","year":"2008","journal-title":"J. Am. Geriatr. Soc."},{"key":"B34","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.clinbiochem.2018.06.011","article-title":"Alzheimer\u2019s disease in the omics era.","volume":"59","author":"Sancesario","year":"2018","journal-title":"Clin. Biochem."},{"key":"B35","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.pscychresns.2015.08.014","article-title":"Neuroimaging of hippocampal atrophy in early recognition of Alzheimer\u2019s disease\u2013a critical appraisal after two decades of research.","volume":"247","author":"Schr\u00f6der","year":"2016","journal-title":"Psychiatry Res. Neuroimaging"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1021\/es5002105","article-title":"Identifying small molecules via high resolution mass spectrometry: communicating confidence.","volume":"48","author":"Schymanski","year":"2014","journal-title":"Environ. Sci. Technol."},{"key":"B37","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0197-0186(02)00041-4","article-title":"Ammonia and Alzheimer\u2019s disease.","volume":"41","author":"Seiler","year":"2002","journal-title":"Neurochem. Int."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.3233\/JAD-160841","article-title":"Glucose Transporters in Brain: In Health and in Alzheimer\u2019s Disease.","volume":"55","author":"Szablewski","year":"2017","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"B39","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.dadm.2015.11.002","article-title":"Cerebral atrophy in mild cognitive impairment: A systematic review with meta-analysis.","volume":"1","author":"Tabatabaei-Jafari","year":"2015","journal-title":"Alzheimers Dement."},{"key":"B40","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/WCO.0b013e32833b764c","article-title":"Imaging genomics.","volume":"23","author":"Thompson","year":"2010","journal-title":"Curr. Opin. Neurol."},{"key":"B41","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.bbadis.2013.06.014","article-title":"Recent advances in the application of metabolomics to Alzheimer\u2019s Disease.","volume":"1842","author":"Trushina","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"B42","doi-asserted-by":"publisher","first-page":"e63644","DOI":"10.1371\/journal.pone.0063644","article-title":"Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer\u2019s disease using metabolomics.","volume":"8","author":"Trushina","year":"2013","journal-title":"PLoS One"},{"key":"B43","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1093\/bioinformatics\/btx656","article-title":"xMWAS: a data-driven integration and differential network analysis tool.","volume":"34","author":"Uppal","year":"2018","journal-title":"Bioinformatics"},{"key":"B44","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1471-2105-14-15","article-title":"xMSanalyzer: automated pipeline for improved feature detection and downstream analysis of large-scale, non-targeted metabolomics data.","volume":"14","author":"Uppal","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1021\/acs.analchem.6b01214","article-title":"xMSannotator: An R Package for Network-Based Annotation of High-Resolution Metabolomics Data.","volume":"89","author":"Uppal","year":"2017","journal-title":"Anal. Chem."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1021\/acs.chemrestox.6b00179","article-title":"Computational Metabolomics: A Framework for the Million Metabolome.","volume":"29","author":"Uppal","year":"2016","journal-title":"Chem. Res. Toxicol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1126\/science.aay3164","article-title":"The exposome and health: Where chemistry meets biology.","volume":"367","author":"Vermeulen","year":"2020","journal-title":"Science"},{"key":"B48","doi-asserted-by":"publisher","first-page":"719","DOI":"10.3389\/fneur.2017.00719","article-title":"Application of Metabolomics in Alzheimer\u2019s Disease.","volume":"8","author":"Wilkins","year":"2018","journal-title":"Front. Neurol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1136\/jnnp-2014-309105","article-title":"Relation between subcortical grey matter atrophy and conversion from mild cognitive impairment to Alzheimer\u2019s disease.","volume":"87","author":"Yi","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1021\/pr301053d","article-title":"Hybrid feature detection and information accumulation using high-resolution LC-MS metabolomics data.","volume":"12","author":"Yu","year":"2013","journal-title":"J. Proteome Res."},{"key":"B51","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3389\/fnagi.2014.00260","article-title":"TAsDNI. Integrative analysis of multi-dimensional imaging genomics data for Alzheimer\u2019s disease prediction.","volume":"6","author":"Zhang","year":"2014","journal-title":"Front. Aging Neurosci."}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2021.796067\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T09:36:38Z","timestamp":1643103398000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2021.796067\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,25]]},"references-count":51,"alternative-id":["10.3389\/fnagi.2021.796067"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2021.796067","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,25]]},"article-number":"796067"}}